Cattle Vaccine and DIVA Field Trials

Cattle Vaccine and DIVA Field Trials

Supplier Days to be held in September.

United Kingdom-London: Research and development services and related consultancy services

2013/S 157-274175

Prior information notice

Services

Directive 2004/18/EC

Section I: Contracting authority

I.1)Name, addresses and contact point(s)

Defra
17 Nobel House
For the attention of: Mick Dunham
SW1P 3JR London
UNITED KINGDOM
Telephone: +44 1904456370
E-mail: mick.dunham@defra.gsi.gov.uk

Further information can be obtained from: The above mentioned contact point(s)

I.2)Type of the contracting authority

National or federal agency/office
I.3)Main activity

Environment
I.4)Contract award on behalf of other contracting authorities

The contracting authority is purchasing on behalf of other contracting authorities: yes

Section II.B: Object of the contract (Supplies or services)

II.1)Title attributed to the contract by the contracting authority:

Cattle Vaccine and DIVA Field Trials
II.2)Type of contract and place of delivery or of performance

Service category No 8: Research and development services
England and Wales
NUTS code UK

II.3)Information on framework agreement
II.4)Short description of nature and quantity or value of supplies or services:

The Animal Health and Veterinary Laboratories Agency (AHVLA) on behalf of Defra and the Governments in Scotland, Wales and Northern Ireland has developed a Bacillus Calmette-Guérin (BCG) cattle vaccine against bovine Tuberculosis (TB) and an accompanying diagnostic test to Differentiate Infected from Vaccinated Animals (DIVA). However, to provide additional data for licensing of the vaccine and international acceptance of the DIVA as a trade test, further data is needed on the performance of the vaccine and DIVA test under UK field conditions. By agreement with the European Commission, Defra are seeking a delivery partner to conduct robust scientific field trials of the vaccine and accompanying DIVA diagnostic test. The field trials will need to be carried out in accordance with Good Clinical Practice (Veterinary) and Animal Test Certificate guidelines.
Work is currently under way to define the scope and scale of these trials which we expect to begin from 2014 and take place mainly in England and Wales, over a period of 2 to 5 years. Draft protocols for the trial would be made available before the start of the trials.
The trials will be expected to:
— Provide validation data to World Organisation for Animal Health (OIE) standards on the sensitivity and specificity of the DIVA test
— Measure the effectiveness of vaccination under UK field conditions.
— Provide further data on the safety of the vaccine.
— Provide information on the practicalities of using BCG cattle vaccine in the field; and
— Possibly collect economic and social science data on cattle vaccination and testing.
Specific requirements will be detailed in the Invitation To Tender (ITT) documentation.
II.5)Common procurement vocabulary (CPV)

73000000, 03321100, 33651690

II.6)Scheduled date for start of award procedures

1.9.2014
II.7)Information about Government Procurement Agreement (GPA)

The contract is covered by the Government Procurement Agreement (GPA): yes
II.8)Additional information:

The Contracting Authority intends to use an eTendering system in this procurement exercise. Two supplier days will be held, one at a London venue on 24th September and another at a Cardiff venue on 30th September. The purpose of the supplier days is to provide a forum for potential suppliers of all sizes to gain a broad understanding of the requirements for a cattle vaccine and DIVA field trial. It will also provide an opportunity to share and gain feedback which may be used to shape and refine the proposition before any formal procurement commences.
All those organisations wishing to attend the supplier day should register their interest via the email address in Section above on or before 19th September.

Section III: Legal, economic, financial and technical information

III.1)Conditions relating to the contract
III.1.1)Main financing conditions and payment arrangements and/or reference to the relevant provisions governing them:

Details will be contained within the Invitation To Tender (ITT) document.
III.2)Conditions for participation
III.2.1)Information about reserved contracts

Section VI: Complementary information

VI.1)Information about European Union funds

The contract is related to a project and/or programme financed by European Union funds: no
VI.2)Additional information:

The Contracting Authority intends to use an eTendering system in this procurement exercise and reserves the right to use a reverse auction.
VI.3)Information on general regulatory framework

VI.4)Date of dispatch of this notice:12.8.2013